Dr. Kanwal Raghav on the Biology of HER2 Gene Amplification in mCRC

Kanwal Raghav, MBBS, MD
Published: Tuesday, Jul 12, 2016


Kanwal Raghav, MBBS, MD, assistant professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, discusses questions regarding HER2 gene amplification in patients with metastatic colorectal cancer (mCRC).
 
There needs to be a better understanding of the biology of HER2 amplified tumors, says Raghav.
 
Amplification is found only in patients who are RAS and RAF wild type, so these are two genes that are routinely tested in colon cancer. Within that group, HER2 amplification occurs only about 8% of the time.
 
Many questions remain regarding the amplification, including if these patients have right-sided or left-sided, are women or men, or if a particular metastatic site is associated with these tumors, says  Raghav.
 

Kanwal Raghav, MBBS, MD, assistant professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, discusses questions regarding HER2 gene amplification in patients with metastatic colorectal cancer (mCRC).
 
There needs to be a better understanding of the biology of HER2 amplified tumors, says Raghav.
 
Amplification is found only in patients who are RAS and RAF wild type, so these are two genes that are routinely tested in colon cancer. Within that group, HER2 amplification occurs only about 8% of the time.
 
Many questions remain regarding the amplification, including if these patients have right-sided or left-sided, are women or men, or if a particular metastatic site is associated with these tumors, says  Raghav.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x